Your browser doesn't support javascript.
loading
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.
Szlosarek, Peter W; Wimalasingham, Akhila G; Phillips, Melissa M; Hall, Peter E; Chan, Pui Ying; Conibear, John; Lim, Louise; Rashid, Sukaina; Steele, Jeremy; Wells, Paula; Shiu, Chiung-Fang; Kuo, Chih-Ling; Feng, Xiaoxing; Johnston, Amanda; Bomalaski, John; Ellis, Stephen; Grantham, Marianne; Sheaff, Michael.
Afiliación
  • Szlosarek PW; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI) - A Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, UK.
  • Wimalasingham AG; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Phillips MM; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Hall PE; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Chan PY; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Conibear J; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Lim L; Department of Clinical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Rashid S; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Steele J; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Wells P; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Shiu CF; Department of Clinical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Kuo CL; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Feng X; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Johnston A; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Bomalaski J; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Ellis S; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Grantham M; Department of Diagnostic Imaging, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
  • Sheaff M; Cytogenetics and Molecular Haematology, Pathology and Pharmacy Building, Barts Health NHS Trust, Royal London Hospital, London, UK.
Cancer Med ; 10(19): 6642-6652, 2021 10.
Article en En | MEDLINE | ID: mdl-34382365
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polietilenglicoles / Cisplatino / Carcinoma de Pulmón de Células no Pequeñas / Pemetrexed / Hidrolasas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polietilenglicoles / Cisplatino / Carcinoma de Pulmón de Células no Pequeñas / Pemetrexed / Hidrolasas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido